Skip to content

Insider · CIK 0001569248

Burow Kristina

Reports to the SEC for 22 companies · CHICAGO, IL

Transactions

50

Companies

22

Filings

5

CIK

0001569248

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-07-01SRRKScholar Rock Holding CorpS Sale−$51.5K
2026-07-01SRRKScholar Rock Holding CorpS Sale−$113K
2026-06-04SRRKScholar Rock Holding CorpA Award—
2026-06-04SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award—
2026-05-27NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2026-04-23SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)M Exercise/Conversion—
2026-04-23SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)M Exercise/Conversion—
2026-04-23SRRKScholar Rock Holding CorpM Exercise/Conversion+$328K
2026-04-23SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)M Exercise/Conversion—
2026-04-23SRRKScholar Rock Holding CorpM Exercise/Conversion+$209K
2026-04-23SRRKScholar Rock Holding CorpM Exercise/Conversion+$133K
2026-04-23SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)M Exercise/Conversion—
2026-04-23SRRKScholar Rock Holding CorpM Exercise/Conversion+$150K
2025-11-13MTSRMetsera, Inc. · Restricted Stock UnitA Award—
2025-11-13MTSRMetsera, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2025-11-13MTSRMetsera, Inc.D Disposition to Issuer—
2025-11-13MTSRMetsera, Inc.D Disposition to Issuer—
2025-11-13MTSRMetsera, Inc.D Disposition to Issuer—
2025-11-13MTSRMetsera, Inc.D Disposition to Issuer—
2025-11-13MTSRMetsera, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2025-11-13MTSRMetsera, Inc.D Disposition to Issuer—
2025-10-27NMRANeumora Therapeutics, Inc.P Purchase+$5M
2025-06-23BOLDBoundless Bio, Inc. · Stock Option (right to buy)A Award—
2025-05-29SRRKScholar Rock Holding CorpS Sale−$131K
2025-05-29SRRKScholar Rock Holding CorpS Sale−$29.2K
2025-05-28NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer—
2025-05-28NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2025-05-28NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer—
2025-05-28NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2025-05-28NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2025-05-22SRRKScholar Rock Holding CorpA Award—
2025-05-22SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award—
2025-05-20MTSRMetsera, Inc. · Stock Option (Right to Buy)A Award—
2025-02-13NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2025-02-13NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2025-02-13NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer—
2025-02-13NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer—
2025-02-03MTSRMetsera, Inc.C Conversion—
2025-02-03MTSRMetsera, Inc.P Purchase+$25.8M
2025-02-03MTSRMetsera, Inc. · Series A Convertible Preferred StockC Conversion—
2025-02-03MTSRMetsera, Inc. · Series B Convertible Preferred StockC Conversion—
2025-02-03MTSRMetsera, Inc.C Conversion—
2025-02-03MTSRMetsera, Inc.P Purchase+$14.2M
2025-02-03MTSRMetsera, Inc. · Series Seed Preferred StockC Conversion—
2025-02-03MTSRMetsera, Inc. · Series A Convertible Preferred StockC Conversion—
2025-02-03MTSRMetsera, Inc. · Series B Convertible Preferred StockC Conversion—
2024-06-27SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award—
2024-06-27SRRKScholar Rock Holding CorpA Award—
2024-06-13NMRANeumora Therapeutics, Inc.A Award—
2024-06-13NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award—